Pharma's trade group spent heavily on search ads to sway public opinion

STAT News reports that PhRMA, the pharmaceutical industry’s trade group, spent an estimated $59 million on search advertising over a seven-year period in an effort to shape American public opinion on prescription drug costs. The outlet’s analysis indicates the spending was directed toward steering blame for high drug prices away from manufacturers and toward pharmacy benefit managers, the intermediaries who negotiate drug prices on behalf of insurers.

According to STAT’s reporting, the ad campaign operated largely outside public notice, reaching consumers through search engine results rather than traditional, more visible advertising channels like television or print. This approach allowed the messaging to appear alongside ordinary search queries about drug pricing, inserting the industry’s preferred framing directly into moments when people sought information.

The report situates this spending within PhRMA’s broader lobbying and public relations apparatus, which has long worked to influence legislation and public sentiment on drug pricing policy. STAT’s figures are drawn from advertising expenditure data compiled over the seven-year window, though the publication notes the full scope of digital influence campaigns of this kind can be difficult to track comprehensively, given the fragmented and often opaque nature of search advertising disclosure.

The specifics of which search platforms carried the ads, and how spending varied year to year, are detailed in STAT’s full account.